UBS Group
SLSN

UBS Group’s Solesence Inc SLSN Stock Holding History

UBS Group’s Portfolio SLSN Stock Details SLSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Sell
12,818
-3,620
-22% -$4.58K ﹤0.01% 8266
2025
Q4 		$26.2K Sell
16,438
-2,612
-14% -$7.08K ﹤0.01% 7602
2025
Q3 		$61.3K Buy
19,050
+6,811
+56% +$24.4K ﹤0.01% 7424
2025
Q2 		$53.4K Buy
+12,239
New +$43K ﹤0.01% 7714

Other funds holding SLSN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group's SLSN Position: Q1 2026 in Review

UBS Group reduced its Solesence Inc (SLSN) stake by 22% in Q1 2026, selling an estimated $4.58K and leaving 12,818 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #8266.

UBS Group first reported a position in SLSN in Q2 2025 and has held it in 4 quarters since. The position peaked at $61.3K in Q3 2025. 49 funds tracked by Wall St. Rank hold SLSN as of Q1 2026.

  • UBS Group held 12,818 shares of Solesence Inc worth $12.2K as of Q1 2026.
  • UBS Group sold 3,620 Solesence Inc shares in Q1 2026, an estimated $4.58K.
  • Solesence Inc made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8266 holding.
  • UBS Group first reported a position in Solesence Inc in Q2 2025 and has held it in 4 quarters since.
  • UBS Group's Solesence Inc position peaked at $61.3K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held Solesence Inc as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.